<DOC>
	<DOCNO>NCT00999336</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics , pharmacodynamics , tolerability betrixaban patient mild , moderate , severe renal impairment healthy volunteer .</brief_summary>
	<brief_title>A Study Determine Pharmacokinetics , Pharmacodynamics , Tolerabiltiy Betrixaban Patients With Mild , Moderate , Severe Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Able understand sign write informed consent . Subjects either normal renal function stable renal disease Subjects require dialysis Evidence active bleeding bleed disorder Unstable clinically significant disorder respiratory , hepatic , metabolic , psychiatric gastrointestinal disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Betrixaban</keyword>
	<keyword>Renal impairment</keyword>
	<keyword>Healthy</keyword>
	<keyword>Kidney dysfunction</keyword>
</DOC>